Letter to the Editor
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Infect Dis. Nov 5, 2021; 11(3): 60-62
Published online Nov 5, 2021. doi: 10.5495/wjcid.v11.i3.60
Can a radioimmunoassay kit be developed for accurate detection of the S protein of severe acute respiratory syndrome coronavirus 2?
Ming-Ming Yu
Ming-Ming Yu, Department of Nuclear Medicine, the Affiliated Hospital of Qingdao University, Qingdao 266100, Shandong Province, China
Author contributions: Yu MM designed and wrote the letter.
Conflict-of-interest statement: Dr. Yu has nothing to disclose.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Ming-Ming Yu, PhD, Doctor, Department of Nuclear Medicine, the Affiliated Hospital of Qingdao University, No. 59 Haier Road, Qingdao 266100, Shandong Province, China. mingmingyu@bjmu.edu.cn
Received: June 19, 2021
Peer-review started: June 19, 2021
First decision: July 31, 2021
Revised: August 18, 2021
Accepted: October 20, 2021
Article in press: October 20, 2021
Published online: November 5, 2021
Core Tip

Core Tip: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is highly infectious, and early detection of SARS-CoV-2 is the key factor in preventing another epidemic. Radioimmunoassay (RIA) exhibits high sensitivity and specificity. The detection of the S protein on the surface of SARS-CoV-2 by RIA is expected to be applied for the early diagnosis of coronavirus disease 2019, which may have a considerable impact on the control of the epidemic.